Inventor · disambiguated record
Michael E. Houston, Jr.
Also filed as: HOUSTON JR MICHAEL · HOUSTON JR MICHAEL E · HOUSTON MICHAEL · HOUSTON MICHAEL E
21 granted patents·33 pending applications·304 citations·filing 1995–2025
95Inventor score
Top patents by PatentIndex Score
54 records- 0197US11219634B2Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cellsGENEVANT SCIENCES GMBH·Filed 2016·Granted Jan 11, 2022·20 cites·12 claims
- 0295US8501824B2Amino acid lipids and uses thereofQUAY STEVEN C·Filed 2011·Granted Aug 6, 2013·48 cites·27 claims
- 0394US5824483AConformationally-restricted combinatiorial library composition and methodPENCE INC·Filed 1995·Granted Oct 20, 1998·173 cites·13 claims
- 0493US9821067B2Lipopeptides for delivery of nucleic acidsMARINA BIOTECH INC·Filed 2015·Granted Nov 21, 2017·7 cites·11 claims
- 0591US7939505B2Amino acid lipids and uses thereofMARINA BIOTECH INC·Filed 2008·Granted May 10, 2011·17 cites·31 claims
- 0690US10660970B2Nucleic acid constructs and methods of using the sameGENEVANT SCIENCES GMBH·Filed 2019·Granted May 26, 2020·7 cites·30 claims
- 0789US10646582B2Block copolymersGENEVANT SCIENCES GMBH·Filed 2017·Granted May 12, 2020·4 cites·16 claims
- 0887US9220785B2Lipopeptides for delivery of nucleic acidsMARINA BIOTECH INC·Filed 2012·Granted Dec 29, 2015·9 cites·11 claims
- 0987US2024325552A1Block copolymersGENEVANT SCIENCES GMBH·Filed 2024·Application pending·0 cites
- 1083US8877729B2Amino acid lipids and uses thereofMARINA BIOTECH INC·Filed 2013·Granted Nov 4, 2014·4 cites·20 claims
- 1182US9867885B2Block copolymersPHASERX INC·Filed 2014·Granted Jan 16, 2018·7 cites·22 claims
- 1278US9339461B2Arginine-based lipids for delivery of therapeuticsMARINA BIOTECH INC·Filed 2014·Granted May 17, 2016·2 cites·20 claims
- 1374US2025186599A1Block copolymersGENEVANT SCIENCES GMBH·Filed 2025·Application pending·0 cites
- 1471US2025276000A1Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cellsGENEVANT SCIENCES GMBH·Filed 2025·Application pending·0 cites
- 1571US2023038687A1Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cellsGENEVANT SCIENCES GMBH·Filed 2022·Application pending·0 cites
- 1670US11938191B2Block copolymersGENEVANT SCIENCES GMBH·Filed 2020·Granted Mar 26, 2024·0 cites·18 claims
- 1770US8063178B2Phage displayed Trp cage ligandsQUAY STEVEN C·Filed 2007·Granted Nov 22, 2011·0 cites·24 claims
- 1869US9340789B2UNA oligomer structures for therapeutic agentsTEMPLIN MICHAEL V·Filed 2009·Granted May 17, 2016·2 cites·9 claims
- 1969US8299236B2Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cellsCHEN LISHAN·Filed 2008·Granted Oct 30, 2012·3 cites·13 claims
- 2067US10023863B2Therapeutics with conformationally restricted monomersMARINA BIOTECH INC·Filed 2015·Granted Jul 17, 2018·1 cites·10 claims
- 2165US2015252369A1Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsMARINA BIOTECH INC·Filed 2014·Application pending·0 cites
- 2264US7329725B1Phage displayed Trp cage ligandsNASTECH PHARM CO·Filed 2004·Granted Feb 12, 2008·0 cites·28 claims
- 2363US2008261304A1Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsNASTECH PHARM CO·Filed 2008·Application pending·0 cites
- 2463US2025108066A1Trinucleotide cap analogs and methods of use thereofTRILINK BIOTECHNOLOGIES LLC·Filed 2023·Application pending·0 cites
- 2562US2010112042A1Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing TherapeuticsMDRNA INC·Filed 2009·Application pending·0 cites
- 2661US2018353607A1Lipids for delivery of therapeuticsMARINA BIOTECH INC·Filed 2017·Application pending·0 cites
- 2760US9731016B2Tyrosine-based lipids for delivery of therapeuticsMARINA BIOTECH INC·Filed 2016·Granted Aug 15, 2017·0 cites·17 claims
- 2857US2006003989A1Compositions and methods using acetylcholinesterase (ACE) inhibitors to treat central nervous system (CNS) disorders in mammalsNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 2957US2015073038A1Delivery molecules for therapeuticsMARINA BIOTECH INC·Filed 2014·Application pending·0 cites
- 3055US2006014289A1Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 3155US2010247482A1Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compoundsNASTECH PHARM CO·Filed 2008·Application pending·0 cites
- 3253US8940857B2Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsAHMADIAN MOHAMMAD·Filed 2010·Granted Jan 27, 2015·0 cites·9 claims
- 3352US2016206749A1Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsMARINA BIOTECH INC·Filed 2015·Application pending·0 cites
- 3451US2013039970A1Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing TherapeuticsMARINA BIOTECH INC·Filed 2012·Application pending·0 cites
- 3551US2017216227A1Delivery molecules for therapeuticsMARINA BIOTECH INC·Filed 2017·Application pending·0 cites
- 3651US2004254146A1Carboxylate salts of galantamine and their pharmaceutical useNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 3750US11684584B2Branched peg molecules and related compositions and methodsGENEVANT SCIENCES GMBH·Filed 2017·Granted Jun 27, 2023·0 cites·10 claims
- 3850US2010129460A1Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeuticsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3950US2010113332A1Method of treating an inflammatory disease by double stranded ribonucleic acidNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 4049US2008076701A1Dicer substrate rna peptide conjugates and methods for rna therapeuticsNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4148US2010240731A1Lipopeptides for delivery of nucleic acidsMDRNA INC·Filed 2010·Application pending·0 cites
- 4247US2012277289A1Activity generating delivery moleculesFAM RENATA·Filed 2010·Application pending·0 cites
- 4347US2006062758A1Tight junction modulator peptide PN159 for enhanced mucosal delivery of therapeutic compoundsNASTECH PHARMACEUTICAL COMAPNY·Filed 2005·Application pending·0 cites
- 4445US2003021795A1Use of coiled-coil structural scaffold to generate structure-specific peptidesFiled 2001·Application pending·0 cites
- 4545US2015209283A1Processes and compositions for liposomal and efficient delivery of gene silencing therapeuticsMARINA BIOTECH INC·Filed 2015·Application pending·0 cites
- 4644US2007275923A1CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERYNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4744US2009220435A1Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agentsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 4843US2013190383A1Nucleic acid compounds with conformationally restricted monomers and uses thereofVAISH NARENDRA K·Filed 2011·Application pending·0 cites
- 4942US2006069021A1Compositions and methods for intranasal administration of inactive analogs of PTH or inactivated preparations of PTH or PTH analogsNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 5042US2016215293A1Una oligomer active structures for therapeutic agentsARCTURUS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →